KeyCorp Issues Positive Forecast for Integer (NYSE:ITGR) Stock Price

Integer (NYSE:ITGR) had its target price lifted by equities research analysts at KeyCorp from $144.00 to $154.00 in a report released on Friday,Benzinga reports. The brokerage currently has an “overweight” rating on the medical equipment provider’s stock. KeyCorp’s target price points to a potential upside of 7.56% from the stock’s previous close.

Other equities analysts have also issued reports about the company. Citigroup upped their target price on Integer from $130.00 to $145.00 and gave the company a “neutral” rating in a report on Wednesday, December 11th. Piper Sandler reaffirmed an “overweight” rating and set a $140.00 target price (up from $125.00) on shares of Integer in a research report on Friday, October 25th. Wells Fargo & Company reiterated an “overweight” rating and set a $160.00 target price on shares of Integer in a research note on Tuesday, December 3rd. Bank of America raised their price objective on shares of Integer from $135.00 to $145.00 and gave the stock a “buy” rating in a report on Tuesday, October 1st. Finally, Benchmark boosted their target price on shares of Integer from $130.00 to $140.00 and gave the company a “buy” rating in a research note on Monday, October 21st. One research analyst has rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $146.56.

Integer Stock Down 0.1 %

ITGR traded down $0.10 during midday trading on Friday, reaching $143.18. 57,034 shares of the company were exchanged, compared to its average volume of 188,065. Integer has a one year low of $94.56 and a one year high of $144.22. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.09 and a current ratio of 3.28. The company’s fifty day moving average price is $136.76 and its 200 day moving average price is $129.33. The company has a market cap of $4.80 billion, a price-to-earnings ratio of 44.20, a price-to-earnings-growth ratio of 1.80 and a beta of 1.12.

Integer (NYSE:ITGR) last released its quarterly earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.07. Integer had a net margin of 6.70% and a return on equity of 11.63%. The business had revenue of $431.42 million for the quarter, compared to analysts’ expectations of $440.59 million. During the same period in the previous year, the company earned $1.27 earnings per share. The firm’s revenue for the quarter was up 8.7% compared to the same quarter last year. As a group, analysts expect that Integer will post 5.33 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the stock. Loomis Sayles & Co. L P raised its holdings in shares of Integer by 3.0% in the 3rd quarter. Loomis Sayles & Co. L P now owns 538,027 shares of the medical equipment provider’s stock valued at $69,943,000 after acquiring an additional 15,446 shares in the last quarter. Jane Street Group LLC lifted its position in Integer by 23.3% during the third quarter. Jane Street Group LLC now owns 151,397 shares of the medical equipment provider’s stock valued at $19,682,000 after purchasing an additional 28,572 shares during the last quarter. Verition Fund Management LLC boosted its holdings in shares of Integer by 17.4% in the 3rd quarter. Verition Fund Management LLC now owns 3,470 shares of the medical equipment provider’s stock worth $451,000 after purchasing an additional 515 shares in the last quarter. Versant Capital Management Inc grew its position in Integer by 98.4% during the fourth quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider’s stock valued at $49,000 after acquiring an additional 183 shares during the last quarter. Finally, Lord Abbett & CO. LLC raised its stake in shares of Integer by 3.5% during the third quarter. Lord Abbett & CO. LLC now owns 290,120 shares of the medical equipment provider’s stock worth $37,716,000 after acquiring an additional 9,754 shares in the last quarter. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.